EW vs ICE · P/E 47, rev $1.39B vs P/E 37, rev $12.64B
Edwards Lifesciences Corp (EW) versus Intercontinental Exchange Inc (ICE) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Intercontinental Exchange Inc (ICE) is a financial data & stock exchanges company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported ICE revenue for 2025-12-31 was $12.64B. Net income was $3.31B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
EW currently screens at market cap $49.91B and trailing P/E 46.9. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
Not investment advice. Open the EW and ICE stock pages for the full models.
Not investment advice.